What topics does this cannabis study cover?

This study covers research on: Pain.

Unraveling the Complex Dance of Substances and MS Symptoms

Q: Where was this research published?

Published in Archives of physical medicine and rehabilitation on February 1, 2026.

Daily Temporal Associations Between Use of Psychoactive Substances and Fatigue, Pain, Stress, and Depressive Symptoms in People with Multiple Sclerosis.

Archives of physical medicine and rehabilitation • February 1, 2026 • Moderately Relevant

🤖

AI Summary

This groundbreaking study explores the complex relationship between psychoactive substances and symptoms experienced by people with multiple sclerosis (MS). Researchers used an innovative ecological momentary assessment (EMA) approach, tracking participants' substance use and symptoms through smartphone surveys over a two-year period. The study revealed a dynamic, bidirectional relationship between substance use and MS symptoms, challenging simplistic views of how people manage their condition.

Cannabis emerged as a particularly interesting substance in the research. While it was associated with higher momentary pain, the study highlights the nuanced ways individuals with MS may use different substances to regulate their symptoms. Caffeine showed mixed effects, reducing fatigue but potentially increasing stress, while alcohol and nicotine demonstrated complex interactions with symptoms like stress and pain. This research provides crucial insights into how people with chronic conditions self-medicate and manage their daily experiences.

The findings underscore the importance of personalized approaches to symptom management for people with MS. Rather than presenting a one-size-fits-all solution, the study reveals the highly individual ways patients interact with psychoactive substances. For healthcare providers, this research suggests the need for more compassionate, nuanced conversations about substance use among patients with chronic conditions, recognizing that these substances can be both a coping mechanism and a potential source of additional symptoms.

📄 Original Abstract

To examine daily within-person associations between symptoms reported by people with multiple sclerosis (MS) and psychoactive substance use using ecological momentary assessment (EMA). This secondary analysis used EMA data collected four times daily for 14 days at baseline, 1-year, and 2-year follow-ups. Community PARTICIPANTS: Ambulatory adults with MS (N= 258). Participants completed daily EMAs via smartphone, reporting use of psychoactive substances and symptoms. Psychoactive substance use (alcohol, caffeine, nicotine, cannabis, opioids) was assessed dichotomously (yes/no). Momentary symptoms, including fatigue, pain, stress, and depressive symptoms, were assessed using brief self-report measures. Mixed-effects logistic regression models assessed lagged associations between symptoms and subsequent substance use; multilevel models examined the reverse direction. Momentary increases in stress predicted lower odds of alcohol use. Higher average pain was linked to reduced alcohol use and increased opioid use. Substance use also predicted symptoms: alcohol, nicotine, and cannabis were associated with greater fatigue, while caffeine predicted reduced fatigue. Cannabis was linked to higher momentary pain, and opioids to higher average pain. Alcohol was associated with reduced stress, whereas caffeine predicted increased stress. MS symptoms and psychoactive substance use are dynamically and bidirectionally related. These findings improve understanding of how individuals with MS use substances for symptom regulation, which may lead to both beneficial and adverse outcomes.

Paper Type

📄 Research

Publication

Journal: Archives of physical medicine and rehabilitation
Published: February 1, 2026
PMID: 41633444
DOI: 10.1016/j.apmr.2026.01.014

Authors (5)

Jeeyeon Kim Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, United States. Electronic address: jeeyeonk@umich.edu.
Dawn M Ehde Department of Rehabilitation Medicine, University of Washington, Seattle, WA, United States.
Kevin N Alschuler Department of Rehabilitation Medicine, University of Washington, Seattle, WA, United States; Department of Neurology, University of Washington, Seattle, WA, United States.
Nora E Fritz Department of Health Care Sciences, Wayne State University, Detroit, MI, United States; Department of Neurology, Wayne State University, Detroit, MI, United States.
Anna L Kratz Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, United States.